The interaction of cadmium sulphide nanoparticles [(CdS)n] with proteins has been studied by resonance Rayleigh scattering spectra (RRS). Below the isoelectric point, proteins such as bovine serum albumin (BSA), human serum albumin (HSA), lysozyme (Lys), hemoglobin (HGB), and ovalbumin (OVA) can bind with CdSn to form macromolecules by virtue of electrostatic attraction and hydrophobic force. It can result in the enhancement of resonance Rayleigh scattering spectra (RRS) intensity. Their maximum scattering peaks were 280 nm, and there was a smaller peak at 370 nm. The scattering enhancement (ΔIRRS) is directly proportional to the concentration of proteins. A new RRS method for the determination of trace proteins using uncapped CdSn nanoparticles probe has been developed. The detection limits are 19.6 ng/mL for HSA, 16.7 ng/mL for BSA, 18.5 ng/mL for OVA, 80.2 ng/mL for HGB, and 67.4 ng/mL for Lys, separately. In this work, the optimum condition of reaction, the effect of foreign, and the analytical application had been investigated.
1. Introduction
In recent years, nanoparticles (NPs) are gaining an intensive interest in many academic and industrial fields, especially their use in detection of proteins and DNA [1, 2]. This is not only due to the unique optical properties of these NPs, such as size-dependent tunable emission wavelength and exceptional photochemical stability but also due to their dimensional similarities with biological molecules [3]. Recently, The interaction of cadmium sulphide nanoparticles [(CdS)n] with protein has been studied using various methods, such as UV-Vis spectroscopy [4], fluorescence spectroscopy [5], Raman spectroscopy [6], dynamic light scattering [6], scanning electron microscopy, and X-ray diffraction [7]. However, Asja Jhonsi et al. discovered that the interaction between uncapped CdS and BSA was very weak [3]. So, a lot of studies have focused on capped CdS nanoparticles by using various capping agents, such as thioglycerol [8], L-cysteine [9], acrylic acid [10], and starch [11]. And the results show that the most sensitive quantitation of protein is generally based on their fluorescence enhancement effect on organic dyes. However, the organic fluorophores often suffer from photobleaching, low signal intensities, and random on/off light emission [12, 13]. So, further studies of interaction between uncapped CdS nanoparticles and protein are significant for some new methods.
We have found that the chemically unmodified gold nanoparticles can be used as some spectral probes by the method of resonance Rayleigh scattering intensity (RRS) [14]. The structure of gold nanoparticles prepared by the sodium citrate reduction method is composed of a metal inner core (Au0) and the surface of Au+ with positive charges. Because of the electrostatic force, hydrogen bond, and hydrophobic effects, self-assembly of citrate anions will occur on the surface of gold nanoparticles to form supermolecular compounds with negative charges which can further react with some proteins, the amino acid residues of which are positively charged. The large volume aggregates cause the change of the absorption spectra and a red shift of the maximum absorption wavelength, at the same time the obvious enhancement of RRS.
At present, our study shows that, in hexametaphosphate medium, the surface of CdS nanoparticle has positive charges, on which the hexametaphosphate anion is self-assembled by electrostatic attraction to form {(CdS)n[(PO3)6]m}x- complex. The anionic complex can bind further with protein cation because the amino acid residues of BSA, HSA, Lys, HGB, and OVA are positively charged in the optimum pH buffer solution. The spectral features of the products form by (CdS)n and the five proteins are similar. The significant enhancement of RRS intensity and new RRS spectrum are observed. This method has high sensitivity and the detection limits are in the range of 16.7–80.2 ng/mL for different proteins. So it is suitable for the determination of trace amount of proteins.
2. Experimental2.1. Apparatus and Chemicals
A Hitachi F-7500 spectrofluorophotometer (Tokyo, Japan) was used to record the RRS and measure the scattering intensities. A PHS-3C pH meter (Shanghai Dazhong Analytical Instrument Plant, China) was used to adjust pH. The high resolution transmission electron microscopy (HRTEM) images were obtained with Philips (Tecnai series) transmission electron microscope operated at 300 keV. Surface charge measurements were performed with a Zeta Potential Analyzer (BECKMAN, Delsa 440SX). The crystalline phases of the samples were investigated by X-ray powder diffraction (XRD) with a Rigaku D/max 2200 Diffractometer with CuKα(λ=1.542Å) radiation operated at 36 kV and 30 mA.
Cadmium Chloride (CdCl2·9H2O) solution was 0.1 mol/L. Thioacetamide (CH3CSNH2, TAA) solution was 0.1 mol/L. Sodium hexametaphosphate solution [Na6(PO3)6] was 0.1 mol/L.
Protein solutions: all the working solutions of human serum albumin (HSA, Sino-American Biotechnology Company), bovine serum albumin (BSA, Sino-American Biotechnology Company), lysozyme (Lys, Sino-American Biotechnology Company), hemoglobin (HGB, Sino-American Biotechnology Company), and ovalbumin (OVA, Sino-American Biotechnology Company) were 50.0 μg/mL.
Britton-Robinson (BR) buffer solution: different pH buffer solutions were prepared by mixing 0.2 mol/L NaOH and the mixture of 0.04 mol/L H3PO4, H3BO3, and CH3COOH in a suitable proportion.
All reagents were analytical reagent grade and doubly distilled water was used.
2.2. Preparation of Cadmium Sulphide Nanoparticles [(CdS)n]
Cadmium sulphide nanoparticles [(CdS)n] were prepared as follows. 1.0 mL of 0.1 mol/L CdCl2 and about 80 mL water were added in a 150 mL beaker. 10.0 mL of 0.01 mol/L CH3CSNH2 was added and then 1.5 mL of 0.1 mol/L sodium hexametaphosphate was added into the solution as a stabilizer. With a strong magnetic stirring, 0.10 mol/L NaOH solution was added in order to adjust pH to 10.4. After setting the solution aside for 30 min, the solution was transferred into a 100 mL calibrated flask and diluted to the mark with water.
2.3. Experimental Procedure
In a 10 mL calibrated flask, appropriate amounts of working proteins such as HSA, BSA, HGB, Lys and OVA, (CdS)n nanoparticles, and buffer solution were added in turn, mixed and finally diluted to the mark with doubly distilled water, mixed. The RRS intensity of the solutions was recorded by synchronous scanning at λex=λem. The RRS intensity of the binding product (IRRS) and the reagent blank (IRRS0) were measured at the maximum wavelength, and ΔIRRS=IRRS-IRRS0.
3. Results and Discussion3.1. X-Ray Powder Diffraction of (CdS)n Nanoparticles
To confirm the formation of (CdS)n nanoparticles, the phase purity and crystallinity of the sample were monitored by X-ray powder diffraction (Figure 1). As shown in the figure, the sample shows the identical diffraction patterns. No significant difference can be observed. In addition, all the peaks are a little wide. According to the JCPDF standard card no. 075-0581, the patterns can be indexed to hawleyite structure. The average grain size was calculated from the 111 peaks (26.5°) using the Scherrer equation. The average CdS size is about 4.6 nm.
The XRD pattern of (CdS)n.
3.2. Resonance Rayleigh Scattering Spectra
The RRS spectra of (CdS)n protein systems are shown in Figure 2. We can see from it that under the experimental condition: (1) the RRS intensity of(CdS)n and the maximum RRS peaks are located at 275 nm; however, proteins themselves have weak RRS; (2) when (CdS)n interact with proteins, the RRS intensities are greatly enhanced, the maximum RRS peaks are located at 280 nm, and new weak shoulder peak appears at 370 nm; (3) the order of the relative scattering intensities is BSA>HSA>OVA>Lys>HGB.
The RRS spectra of binding products of (CdS)n with proteins. 1:(CdS)n, 2: HSA, 3: BSA, 4: OVA, 5: HGB, 6: Lys, 7: (CdS)n-HGB, 8: (CdS)n-Lys, 9: (CdS)n-OVA, 10: (CdS)n-HSA, and 11: (CdS)n-BSA. Proteins concentrations: 2.5 μg/mL; (CdS)n concentration: 6.0×10-5 mol/L.
Taking HSA as an example, Figure 3 shows that the enhancement of RRS intensity for (CdS)n-HSA system is coincident with an increased concentration of HSA. Hence, the RRS method can be applied to the determination of proteins.
The RRS spectra of (CdS)n-HAS. and 1: (CdS)n and 2~9: HAS-(CdS)n (HSA concentration: 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 μg/mL); (CdS)n concentration: 6.0 × 10-5 mol/L.
3.3. Optimum Solution Acidity for the Reaction
Three buffer solutions such as HAc-NaAc, BR, and HCl-NaAc were used to investigate the effects of solution acidity on the RRS. The results showed that the BR buffer solution was the most suitable. The effects of BR buffer solution acidity on the RRS intensity of the (CdS)n-HSA system are shown in Figure 4. It can be seen that the optimum pH range of the actions was 3.0~4.9. If pH was higher than 5.0, ΔIRRS decreased remarkably. In this work, we chose pH 3.3 as reaction acidity, and the appropriate volume was 0.5 mL.
Effect of acidity on ΔIRRS. HSA concentrations: 2.5 μg/mL; CdS concentration: 6.0 × 10−5 mol/L.
3.4. Effects of the Amounts of (CdS)n Nanoparticles
The effects of the amounts of (CdS)n nanoparticles solution ([(CdS)n] = 5.0 × 10−5 mol/L) on RRS of five systems were investigated. The results shown in Figure 5 revealed that the optimum amounts are 6.0 × 10−5 mol/L for HSA system, 6.0 × 10−5 mol/L for BSA system, 4.0 × 10−5 mol/L for OVA system, 5.0 × 10−5 mol/L for Lys system, and 7.0 × 10−5 mol/L for HGB system. If the (CdS)n nanoparticles concentration was lower or higher than the previous concentrations, RRS intensities became lower. So, 6.0 × 10−5 mol/L, 6.0 × 10−5 mol/L, 4.0 × 10−5 mol/L, 5.0 × 10−5 mol/L, and 7.0 × 10−5 mol/L were chosen, respectively, as suitable HAS, BSA, OVA, Lys, and HGB concentrations, respectively.
Effect of the concentration of CdS nanoparticles. HSA concentrations: 2.5 μg/mL; pH 3.3.
3.5. Reaction Speed and the Stability
Under the optimum experimental conditions, the formation velocity and the time of stability were studied. The reactions completed in about 10 minutes at room temperature and the ΔIRRS was kept constant for 2 hours. All results showed that the reactive products had good stability.
3.6. Sensitivity of Method
Under the optimum conditions, when (CdS)n interacted with the proteins of different concentrations to form complex product, the RRS intensity at the maximum wavelength was measured. The calibration graphs of RRS intensity versus the concentrations of proteins were constructed. The linear ranges, relevant coefficients, and the detecting limits are listed in Table 1 and compared with other RRS methods (Table 2).
Linear ranges, correlation coefficient, and detection limits.
Detected protein
Measurement wavelength/(nm)
Linear regression equation/(c = μg/mL)
Correlation coefficient
Linear ranges/(μg/mL)
Detection limits/(ng/mL)
HSA
282
ΔI=253.6+1186.3c
0.9997
0.065~5.0
19.6
BSA
283
ΔI=315.4+1393.6c
0.9963
0.056~4.5
16.7
OVA
282
ΔI=-153.1+1255.6c
0.9985
0.062~5.0
18.5
HGB
280
ΔI=20.5+290.1c
0.9974
0.267~4.0
80.2
Lys
287
ΔI=117.4+344.8c
0.9968
0.223~4.0
67.4
Comparison of sensitivities of some RRS methods for the determination of HSA.
Reagents
Determination wavelength (nm)
Linear ranges (μg/mL)
Detection limits (ng/mL)
Reference
Alizarin Red S
360
0.2~15.5
9.51
[15]
PSbMoB
470
0~4.0
12.5
[16]
Chrome azurol S-Al3+
410
2.5~60
89.6
[17]
Chlorophosphonazo III (CPAIII)
417
0~4.9
70.5
[18]
Chrome azurol S (CAS)
370
0~1.0
20.0
[19]
Gold nanoparticles
303
0.0013~0.45
0.38
[14]
CdS particles
280
0.065~4.5
19.6
This work
3.7. Binding (CdS)n Nanoparticles with Proteins
It is a general thinking that the (CdS)n nanoparticles prepared by CdCl2 and TAA with the stabilizer of sodium hexametaphosphate [Na6(PO3)6] are composed of CdS nucleus and Cd2+ crust. It makes the surface of nanoparticles positively charged. There are large amounts of (PO3)66-which can self-assemble on the surface of (CdS)n nanoparticle by electrostatic attraction. It forms the supermolecule compound of {(CdS)n[(PO3)6]m}x- with negative charges. Simultaneously, in this work, the selected optimum pH is below the isoelectric points of proteins (PI). In this case, α-COOH and –COOH of side chain of amino acid residues in peptide chain do not dissociate, while protonation of α-NH2 and ε-NH2 will make them become –NH3+; hence, proteins are positively charged macromolecules in the solution. The (CdS)n nanoparticles bind proteins through the “bridge” of (PO3)66- surrounding the surface of the nanoparticles, and α-NH3+ and ε-NH3+ of amino acid residues in peptide chain will bind (PO3)66- by electrostatic force. Thus, the combined products of proteins and (CdS)nnanoparticles may be {(CdS)n[(PO3)6]m}x-(Py+)l.
In Figures 6(a), 6(b), 6(c), and 6(d), the shape of the (CdS)n nanoparticles and combined products were observed by HRTEM. It showed that (1) the (CdS)n nanoparticles were well distributed in the solution, and the mean diameters of them were 4 nm (±2 nm); (2) when HSA was added into the solution of (CdS)n nanoparticles, the mean diameters of the nanoparticles did not increase too much, but HSA molecules bound with the nanoparticles led the nanoparticles to gather. From Figure 6(d), the gathering of two (CdS)n nanoparticles could be observed. The conclusion derived from that the lattice line of (CdS)n nanoparticle was fuzzy, which was in accordance with the result of XRD. The results of zeta potential measurement were shown in Figures 7(a), 7(b), and 7(c). The zeta potential of (CdS)n nanoparticles and HAS was located at −20.6 mV and 4.1 mV, respectively. The reaction mixture exhibited two peaks in the result of zeta potential analysis and in Figure 7(c) the two zeta potentials were −12.9 mv and −36.8 mv, presumably as a result of two different charge particles in solution. This result also presents that the nanoparticles will further gather.
The HRTEM images of (CdS)nand the binding products of HAS. c(CdS)n=6.0×10-4mol/L; cHSA4.0g/mL; c(CdS)n=6.0×10-4mol/L. (a) Typical HRTEM image of the(CdS)n, (b) shows the details of the(CdS)n. (c) Typical HRTEM image of the (CdS)n binding with HAS. (d) shows the details of the binding product between (CdS)n and HAS.
The zeta potential images of (CdS)n and the binding products of HAS. (a) The zeta potential image of(CdS)n. (b) The zeta potential image of HSA. (c) The zeta potential image of the (CdS)n binding with HAS.
3.8. Effects of Binding the (CdS)n Nanoparticles with Proteins on RRS Spectral Characteristics
The RRS intensities of (CdS)n nanoparticles or proteins are very weak when they are independent, but when they co-exist in buffer solution, the RRS intensities are enhanced greatly. The reasons are as follows.
Change of the conformation of the proteins and formation of macromolecules. The scattering of the proteins is weak because the proteins are stable spherical and small in the aqueous. After binding (CdS)n nanoparticles with proteins, α-NH3+ and ε-NH3+ of the peptide chain of proteins bind with (PO3)66- by electrostatic force; the original regular and repeating secondary structures of the protein held together by peptide chain and a hydrogen bond were destroyed and the structure become extended and loose, which is similar to the denaturation of protein. It makes the proteins aggregate to macromolecules, which enlarges the volume of compound enhancing the scattering intensity.
Enhancement of hydrophobicity. After binding proteins with c(CdS)n nanoparticles, most of their electric charges are neutralized, and the hydrophobic group is exposed. Therefore, the hydrophobicity of the binding products increases and a liquid–solid interface between the complex and the water may form, which produces surface enhanced scattering.
3.9. Selectivity of RRS Method3.9.1. Effect of Foreign Substance
Taking HSA as an example, the effects of the metal ions, inorganic anions, some amino acids, and saccharides on the system were tested. When the HSA concentration was 2.5 μg/mL, the existence of Al3+, Mg2+, Mn2+, Fe3+ at 10 times, Cu2+, Ca2+ at about 20 times, Zn2+ at 240 times, K+ at 200 times, and large numbers of common amino acids, saccharides, inorganic anions, and vitamins did not interfere with the determination.
3.9.2. Determination of HSA in the Composite Samples
The proposed RRS method was applied to determine HSA in composite samples. The results were listed in Table 3. By using standard addition recovery method, the relative standard deviations (RSD) of found values were between 0.54 and 2.0%, and the recoveries were between 93.5 and 112.0%. There is no significant difference between added and found values.
Results of the determination of proteins in synthesized samples using the RRS method.
3.9.3. Determination of HSA in the Human Urine Samples
Three copies of fresh urine samples (healthy human) were filtrated after being placed for one night. A 10 mL aliquot of each copy was diluted 10 times. Then a 1.0 mL aliquot of each solution was placed in the calibrated flask followed by 1.0 mL of BR buffer solution and 0.5 mL of (CdS)n solution. HSA was used as the standard for the determination of protein. The results are listed in Table 4 (U.1~U.3). Each serum sample was determined for 5 times and the relative standard deviations (RSD) were between 3.5 and 4.6%.
Results for the determination of HSA in urine and serum samples.
Samples
RRS method
CBB G-250 method
Determined concentration (μg/mL)
RSD (%, n=5)
Determined concentration (μg/mL)
RSD (%, n=5)
U.1
4.2
3.7
4.8
2.3
U.2
4.9
3.5
5.1
2.1
U.3
5.1
4.6
5.2
2.4
S.1
65.4
3.4
62.7
2.9
S.2
67.7
3.1
69.4
3.4
S.3
61.6
2.6
63.1
2.7
3.9.4. Determination of HSA in the Human Serum
Three copies of fresh serum samples (healthy human) were diluted 1000 times, from 1.0 mL to 1.0 L. A 0.5 mL aliquot of each solution was placed in the calibrated flask followed by 1.0 ml of BR buffer solution and 0.5 mL of (CdS)nsolution. HSA was used as the standard for the determination of protein. The results are listed in Table 4 (S.1~S.3). Each serum sample was determined for 5 times and the relative standard deviations (RSD) were between 2.6 and 3.4%.
All results were satisfactory in comparison with the results determined by spectrophotometry with CBB G-250. The result shows that this method is good at determining the content of protein in complicated biological samples.
Conflict of Interests
The authors declare that they do not have any commercial or associative interest that represents a conflict of interests in connection with the work submitted.
Acknowledgments
The present work was supported by The National Natural Science Foundation of China (21003066), the Hechi University foundation (2013ZB-N001), and Hechi city foundation (1171104-010).
CurriM. L.AgostianoA.LeoG.MallardiA.CosmaP.Della MonicaM.Development of a novel enzyme/semiconductor nanoparticles system for biosensor application20022224494522-s2.0-003692119210.1016/S0928-4931(02)00191-1TangS. H.LiY. Q.Interaction via in situ binding of CdS nanorods onto gelatin2011360171772-s2.0-7995787513510.1016/j.jcis.2011.04.040JhonsiM. A.KathiravanA.RenganathanR.Spectroscopic studies on the interaction of colloidal capped CdS nanoparticles with bovine serum albumin20097221671722-s2.0-6734918261210.1016/j.colsurfb.2009.03.030JiangL.YangB. Q.MaY. D.The binding of phosphorothioate oligonucleotides to CdS nanoparticles20032801-2293310.1016/j.cplett.2003.08.087ShenX. C.LiouX. Y.YeL. P.LiangH.WangZ.Spectroscopic studies on the interaction between human hemoglobin and CdS quantum dots200731124004062-s2.0-3424834293910.1016/j.jcis.2007.03.006DattaA.SahaA.SinhaA. K.BhattacharyyaS. N.ChatterjeeS.Synthesis of CdS nanoparticles in colloidal state and its possible interaction with tyrosine200578169752-s2.0-1184429834110.1016/j.jphotobiol.2004.10.001MezianiM. J.PathakP.HarruffB. A.HurezeanuR.SunY.Direct conjugation of semiconductor nanoparticles with proteins2005215200820112-s2.0-1484431451310.1021/la0478550KulkarniS. K.EthirajA. S.KharraziS.DeobagkarD. N.DeobagkarD. D.Synthesis and spectral properties of DNA capped CdS nanoparticles in aqueous and non-aqueous media2005211951022-s2.0-2044450209910.1016/j.bios.2004.09.004DingL.ZhouP. J.LiS. Q.ShiG. Y.ZhongT.WuM.Spectroscopic studies on the thermodynamics of L-cysteine capped CdSe/CdS quantum dots-BSA interactions201121117242-s2.0-7995151771710.1007/s10895-010-0685-2ChenH. Q.XuF.HongS.WangL.Quantitative determination of proteins at nanogram levels by the resonance light-scattering technique with composite nanoparticles of CdS/PAA20066524284322-s2.0-3374787578610.1016/j.saa.2005.10.055RodriguezP.Munoz-AguirreN.San-Martin MartinezE.de la CruzcG. G.TomasS. A.AngelO. Z.Synthesis and spectral properties of starch capped CdS nanoparticles in aqueous solution2008310116016410.1016/j.jcrysgro.2007.09.036WangL. Y.ZhouY. Y.WangL.ZhuC.LiY.GaoF.Synchronous fluorescence determination of protein with functionalized CdS nanoparticles as a fluorescence probe2002466187922-s2.0-003715170210.1016/S0003-2670(02)00553-6DattaA.ChatterjeeS.SinhaA. K.BhattacharyyaS. N.SahaA.Identification of tyrosine in the presence of tryptophan using Cd2+-enriched colloidal CdS nanoparticles: a fluorescence spectroscopic study200612125535602-s2.0-3375100937210.1016/j.jlumin.2005.12.045LiuS. P.YangZ.LiuZ. F.KongL.Resonance Rayleigh-scattering method for the determination of proteins with gold nanoparticle probe200635311081162-s2.0-3364635540710.1016/j.ab.2006.03.012HuX. L.FengP.LiY. F.Interactions of pyrogallol red with proteins and the determination of proteins by resonance light scattering1998235561566LongX. F.LiuS. P.Resonance Rayleigh scattering method for the determination of protein with PSbMo heteropoly blue2000252155159YangR.LiuS. P.HuangC. Z.Resonance Rayleigh scattering method for the determination of proteins with aluminum-chrome azurol S chelate199926365LiuS. P.FanL.LongX. F.Resonance Rayleigh scattering method for the determination of proteins with chlorophosphonazo III2001263293296WeiY. J.LiK. A.TongS. Y.Elastic light-scattering of protein-chrome azurol S complex and its preliminary analytical application19985632962972-s2.0-0006188486